Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne

NCT04416308 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT04416308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04416308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne
Lead sponsor
Rennes University Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 29, 2020
Completion date
October 12, 2020
Enrollment
9,453 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus